About
Site Map
Contact Us
Search
Search
A service of the
U.S. National Library of Medicine®
Home
Conditions
Genes
Chromosomes
Handbook
Glossary
Resources
Genes
>
GPC3
>
References
These sources were used to develop the Genetics Home Reference
gene summary
on the
GPC3
gene.
Davoodi J, Kelly J, Gendron NH, MacKenzie AE. The Simpson-Golabi-Behmel syndrome causative glypican-3, binds to and inhibits the dipeptidyl peptidase activity of CD26. Proteomics. 2007 Jun;7(13):2300-10.
PubMed citation
DeBaun MR, Ess J, Saunders S. Simpson Golabi Behmel syndrome: progress toward understanding the molecular basis for overgrowth, malformation, and cancer predisposition. Mol Genet Metab. 2001 Apr;72(4):279-86. Review.
PubMed citation
Entrez
Gene
Filmus J. Glypicans in growth control and cancer. Glycobiology. 2001 Mar;11(3):19R-23R. Review.
PubMed citation
Gene Review: Simpson-Golabi-Behmel Syndrome Type
1
Jakubovic BD, Jothy S. Glypican-3: from the mutations of Simpson-Golabi-Behmel genetic syndrome to a tumor marker for hepatocellular carcinoma. Exp Mol Pathol. 2007 Apr;82(2):184-9. Epub 2007 Jan 26. Review.
PubMed citation
Midorikawa Y, Ishikawa S, Iwanari H, Imamura T, Sakamoto H, Miyazono K, Kodama T, Makuuchi M, Aburatani H. Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling. Int J Cancer. 2003 Feb 10;103(4):455-65.
PubMed citation
Sakazume S, Okamoto N, Yamamoto T, Kurosawa K, Numabe H, Ohashi Y, Kako Y, Nagai T, Ohashi H. GPC3 mutations in seven patients with Simpson-Golabi-Behmel syndrome. Am J Med Genet A. 2007 Aug 1;143A(15):1703-7.
PubMed citation
Song HH, Shi W, Xiang YY, Filmus J. The loss of glypican-3 induces alterations in Wnt signaling. J Biol Chem. 2005 Jan 21;280(3):2116-25. Epub 2004 Nov 10.
PubMed citation
Reviewed: February 2008
Published: June 17, 2013
Indicates a page outside Genetics Home Reference.